Savior Lifetec Corporation (4167.TWO)
TWD 17.65
(-9.95%)
TWD 17.65
(-9.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 220.94 Million TWD | 68.68% |
| 2022 | 130.99 Million TWD | -57.45% |
| 2021 | 307.86 Million TWD | -44.89% |
| 2020 | 558.64 Million TWD | 59.16% |
| 2019 | 350.99 Million TWD | 597.94% |
| 2018 | -70.48 Million TWD | -116.01% |
| 2017 | 440.34 Million TWD | 135.61% |
| 2016 | 186.89 Million TWD | 326.82% |
| 2015 | -82.39 Million TWD | -543.58% |
| 2014 | 18.57 Million TWD | -74.26% |
| 2013 | 72.15 Million TWD | 129.12% |
| 2012 | -247.75 Million TWD | -79.2% |
| 2011 | -138.25 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 78.39 Million TWD | 45.82% |
| 2024 Q1 | 53.75 Million TWD | -59.41% |
| 2023 Q3 | 6.52 Million TWD | -77.36% |
| 2023 Q4 | 132.44 Million TWD | 1931.02% |
| 2023 FY | 220.94 Million TWD | 68.68% |
| 2023 Q1 | 53.17 Million TWD | 75.25% |
| 2023 Q2 | 28.8 Million TWD | -45.83% |
| 2022 FY | 130.99 Million TWD | -57.45% |
| 2022 Q4 | 30.34 Million TWD | -31.72% |
| 2022 Q2 | 52.51 Million TWD | 1323.94% |
| 2022 Q3 | 44.44 Million TWD | -15.37% |
| 2022 Q1 | 3.68 Million TWD | -86.25% |
| 2021 Q3 | 15.2 Million TWD | -86.31% |
| 2021 Q1 | 154.71 Million TWD | -18.92% |
| 2021 FY | 307.86 Million TWD | -44.89% |
| 2021 Q2 | 111.13 Million TWD | -28.17% |
| 2021 Q4 | 26.81 Million TWD | 76.31% |
| 2020 FY | 558.64 Million TWD | 59.16% |
| 2020 Q3 | 131.43 Million TWD | 21.23% |
| 2020 Q2 | 108.41 Million TWD | -15.29% |
| 2020 Q1 | 127.98 Million TWD | -5.59% |
| 2020 Q4 | 190.81 Million TWD | 45.18% |
| 2019 Q2 | 55.55 Million TWD | -15.7% |
| 2019 Q4 | 135.56 Million TWD | 44.25% |
| 2019 Q3 | 93.97 Million TWD | 69.17% |
| 2019 FY | 350.99 Million TWD | 597.94% |
| 2019 Q1 | 65.89 Million TWD | 786.0% |
| 2018 FY | -70.48 Million TWD | -116.01% |
| 2018 Q4 | -9.6 Million TWD | 78.54% |
| 2018 Q3 | -44.76 Million TWD | -1350.36% |
| 2018 Q2 | 3.58 Million TWD | 118.17% |
| 2018 Q1 | -19.7 Million TWD | -141.43% |
| 2017 FY | 440.34 Million TWD | 135.61% |
| 2017 Q3 | 111.88 Million TWD | -31.07% |
| 2017 Q1 | 118.58 Million TWD | 0.9% |
| 2017 Q2 | 162.32 Million TWD | 36.88% |
| 2017 Q4 | 47.54 Million TWD | -57.5% |
| 2016 Q4 | 117.52 Million TWD | 144.07% |
| 2016 FY | 186.89 Million TWD | 326.82% |
| 2016 Q1 | -19.76 Million TWD | 59.53% |
| 2016 Q3 | 48.15 Million TWD | 17.5% |
| 2016 Q2 | 40.98 Million TWD | 307.37% |
| 2015 Q4 | -48.83 Million TWD | -309.13% |
| 2015 Q3 | -11.93 Million TWD | -21.57% |
| 2015 FY | -82.39 Million TWD | -543.58% |
| 2015 Q2 | -9.81 Million TWD | 16.92% |
| 2015 Q1 | -11.81 Million TWD | -253.77% |
| 2014 Q3 | -28.87 Million TWD | -253.43% |
| 2014 FY | 18.57 Million TWD | -74.26% |
| 2014 Q4 | 7.68 Million TWD | 126.61% |
| 2014 Q2 | 18.82 Million TWD | -10.15% |
| 2014 Q1 | 20.94 Million TWD | 101.27% |
| 2013 Q1 | 16.68 Million TWD | 135.42% |
| 2013 Q4 | 10.4 Million TWD | -63.33% |
| 2013 FY | 72.15 Million TWD | 129.12% |
| 2013 Q3 | 28.38 Million TWD | 70.13% |
| 2013 Q2 | 16.68 Million TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 FY | -247.75 Million TWD | -79.2% |
| 2012 Q4 | -47.09 Million TWD | 0.0% |
| 2012 Q3 | -47.09 Million TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 FY | -138.25 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -67057.751% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 45.112% |
| Level Biotechnology Inc. | 219.54 Million TWD | -0.64% |
| Sagittarius Life Science Corp | 71.47 Million TWD | -209.119% |
| NeoCore Technology Co., Ltd. | -9.08 Million TWD | 2532.02% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 1.902% |
| GlycoNex Incorporation | 995 Thousand TWD | -22105.93% |
| VBI | 16.42 Million TWD | -1245.363% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | -701.004% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | -11.335% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -42308.637% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -84.262% |
| Visgeneer Inc. | 67.48 Million TWD | -227.419% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 158.89% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 84.273% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | -52.814% |
| Neith Corporation | 18.01 Million TWD | -1126.2% |
| Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 4.028% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -871.546% |
| Enimmune corporation | -23.37 Million TWD | 1045.317% |
| TaiRx, Inc. | 2.43 Million TWD | -8959.0% |
| CHO Pharma, Inc. | -28.27 Million TWD | 881.318% |
| EirGenix Inc. | 236.74 Million TWD | 6.671% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -111.736% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 22.617% |
| Lin BioScience, Inc. | -17.92 Million TWD | 1332.493% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | -146.545% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | -173.719% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -20301.57% |
| Lukas Biomedical Inc. | 133.89 Million TWD | -65.023% |
| RBC Bioscience Corporation | 72.89 Million TWD | -203.106% |
| BiOptic Inc. | 152.74 Million TWD | -44.652% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -245398.889% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | -3214.069% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -8349.293% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 65.687% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 1940.935% |
| NaviFUS Corp. | 11.82 Million TWD | -1768.175% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | -128.314% |
| Sinew Pharma Inc. | -28.98 Million TWD | 862.287% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -70490.735% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 43.701% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -432.651% |
| AP Biosciences Inc | 32.25 Million TWD | -585.049% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 64.209% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -4089.401% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 29.746% |
| Intech Biopharm Corporation | -163.99 Million TWD | 234.729% |
| Oneness Biotech Co., Ltd. | 32.56 Million TWD | -578.549% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 5583.966% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | 2368.703% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 54.42% |
| TCI GENE Inc. | 174.61 Million TWD | -26.533% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 1430.938% |
| Senhwa Biosciences, Inc. | -10.17 Million TWD | 2271.916% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | -189.356% |
| NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | -187.085% |
| PharmaEngine, Inc. | 718.97 Million TWD | 69.269% |
| TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | -97.831% |
| OBI Pharma, Inc. | -73.49 Million TWD | 400.623% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | -59.105% |
| Acepodia, Inc. | 16.59 Million TWD | -1231.58% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | -704.358% |